Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Epitestosterone may act as a weak antiandrogen and can inhibit an enzyme involved in testosterone metabolism.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Ozenoxacin reduces sebum production, helping manage acne.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Osaterone acetate reduces prostate size and enzyme levels in dogs with benign prostatic hyperplasia.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Finasteride can cause muscle weakness and eye movement issues, even at low doses.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Spironolactone is an effective and safe treatment for acne in adult women.